These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23855290)

  • 1. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fatty liver disease and its risk factors in the population of South China.
    Zhou YJ; Li YY; Nie YQ; Ma JX; Lu LG; Shi SL; Chen MH; Hu PJ
    World J Gastroenterol; 2007 Dec; 13(47):6419-24. PubMed ID: 18081233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
    Li H; Wang YJ; Tan K; Zeng L; Liu L; Liu FJ; Zhou TY; Chen EQ; Tang H
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):377-82. PubMed ID: 19666406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of non-alcoholic fatty liver disease in China.
    Fan JG; Farrell GC
    J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of rs738409, obesity, and alcohol: a population-based autopsy study.
    Dunn W; Zeng Z; O'Neil M; Zhao J; Whitener M; Yu-Jui Wan Y; Mitchell EK; Handler M; Weinman SA
    Am J Gastroenterol; 2012 Nov; 107(11):1668-74. PubMed ID: 23032985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of fatty liver in Portuguese adults.
    Leitão J; Carvalhana S; Cochicho J; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Oliveiros B; Rodrigues V; Sousa R; Sampaio F; Carvalho A; Cortez-Pinto H
    Eur J Clin Invest; 2020 Jun; 50(6):e13235. PubMed ID: 32289180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?
    Völzke H
    World J Gastroenterol; 2012 Jul; 18(27):3492-501. PubMed ID: 22826613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
    Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
    Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.
    Liu CJ
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1555-60. PubMed ID: 22741595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
    Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
    BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China.
    Yan J; Xie W; Ou WN; Zhao H; Wang SY; Wang JH; Wang Q; Yang YY; Feng X; Cheng J
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1654-9. PubMed ID: 23731053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
    Mahli A; Hellerbrand C
    Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
    Craciun A; Lackner C; Cortez-Pinto H
    Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.